Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Vigil Neuroscience to Present in Upcoming June Investor Conferences
-
Incident IQ Partners with Level Access to Enhance Digital Accessibility
-
Aya Gold & Silver Announces Release of Fourth Sustainability Report
-
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
-
Notification on transactions concluded by a person associated to a management body of Grigeo Group AB
-
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment for Unresectable Hepatocellular Carcinoma
-
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
-
Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Within 200m of Reserve Pit and Confirms Continuity of Zone X22 Mineralization to Depth of 550m
-
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
-
Harfang Announces Summer Exploration Plans at Its Gold and CSM Properties in Eeyou Istchee James Bay, Quebec
-
17 Education & Technology Group Inc. to Report First Quarter 2024 Unaudited Financial Results on June 5, 2024
-
Reservoir Media Announces Fourth Quarter and Fiscal Year 2024 Results
-
Lantronix to Showcase AI-Driven Out-Of-Band Management Solutions at Cisco Live
-
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
-
Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
-
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
-
Preqin announces launch of Term Intelligence
-
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
-
ARMLOGI ANNOUNCES EXPANSION AT THE PORT OF SAVANNAH
-
Monte Rosa Therapeutics Announces Leadership Team Promotions
-
Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
-
TECHNATION Hosts Annual Queen’s Park Day to Support the Government’s Plans to Build a Better Ontario
-
Greenridge Exploration Announces Acquisition of the Carpenter Lake Uranium Project in the Athabasca Basin with Multiple High Priority Targets
-
NFI releases its Environmental, Social, and Governance Report for 2023
-
Beamr Cloud upgrade for enterprises: customizable video service with enhanced security and privacy
-
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
-
Amplify ETFs Declares May Income Distributions for its ETFs
-
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
-
Attralus Presents New Data on Its Pan-Amyloid Therapeutic and Diagnostic Candidates at the XIX International Symposium on Amyloidosis (ISA)
-
SPOD Lithium Provides a Strategic Update
-
17 Education & Technology Group Inc. to Report First Quarter 2024 Unaudited Financial Results on June 5, 2024
-
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
-
Rivalry Reports First Quarter 2024 Results, Expands Into Crypto Segment Through Rivalry Token
-
Virtu Financial, Inc. Announces Investor Meetings for Potential Opportunistic Offering of Senior Secured First Lien Notes
-
Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
Village Farms International Boosts Ownership in Fast-Growing Rose LifeScience
-
ARMLOGI ANNOUNCES EXPANSION AT THE PORT OF SAVANNAH
-
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
-
Destination XL Group, Inc. Reports First Quarter Financial Results
-
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
-
Twist Your Tastebuds Three Ways: Good Supply Cannabis Brand Launches ‘Twisted’ All-In-One Vapes
-
PyroGenesis Announces Intent to Exercise Option to Purchase 50% of HPQ Silica Polvere
-
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
-
Gray Names Greg Connor as General Manager of WRDW and WAGT in Augusta, Georgia
-
Release of Annual Report and Audited Financial Statements for the year ended 31 December 2023
-
Harness Therapeutics appoints Leading World Experts in Neurodegenerative Diseases to its Scientific Advisory Board (SAB)
-
Brookfield enters into exclusive negotiations with Impala and other shareholders to acquire a majority stake in Neoen and launch a mandatory tender offer for 100% of the company

